The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
An update on primary hyperoxaluria
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adeno-associated Virus Serotypes: Vector Toolkit for Human Gene Therapy
Wu, Z., Asokan, A., & Samulski, R. J. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.05.009 · Cited by 922
Decramer, S., de Peredo, A. G., Breuil, B., Mischak, H., Monsarrat, B., Bascands, J.-L., & Schanstra, J. P. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r800001-mcp200 · Cited by 450
Allison, M. J., Dawson, K. A., Mayberry, W. R., & Foss, J. G. (1985) · Archives of Microbiology · doi:10.1007/bf00446731 · Cited by 437
Hoppe, B., Beck, B. B., & Milliner, D. S. (2009) · Kidney International · doi:10.1038/ki.2009.32 · Cited by 375
Self-citationHamm, L. L. (1990) · Kidney International · doi:10.1038/ki.1990.265 · Cited by 309
Oxalobacter sp. reduces urinary oxalate excretion by promoting enteric oxalate secretion
Hatch, M., Cornelius, J., Allison, M., Sidhu, H., Peck, A., & Freel, R. W. (2006) · Kidney International · doi:10.1038/sj.ki.5000162 · Cited by 245
Mutations in DHDPSL Are Responsible For Primary Hyperoxaluria Type III
Belostotsky, R., Seboun, E., Idelson, G. H., Milliner, D. S., Becker-Cohen, R., Rinat, C., Monico, C. G., Feinstein, S., Ben-Shalom, E., Magen, D., et al. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.07.023 · Cited by 233
LEUMANN, E., & HOPPE, B. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1291986 · Cited by 228
Self-citationOxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1
Hoppe, B., Beck, B., Gatter, N., von Unruh, G., Tischer, A., Hesse, A., Laube, N., Kaul, P., & Sidhu, H. (2006) · Kidney International · doi:10.1038/sj.ki.5001707 · Cited by 215
Self-citationA United States survey on diagnosis, treatment, and outcome of primary hyperoxaluria
Hoppe, B., & Langman, C. B. (2003) · Pediatric Nephrology · doi:10.1007/s00467-003-1234-x · Cited by 188
Self-citation
Cited by
Medical Management of Kidney Stones: AUA Guideline
Pearle, M. S., Goldfarb, D. S., Assimos, D. G., Curhan, G., Denu-Ciocca, C. J., Matlaga, B. R., Monga, M., Penniston, K. L., Preminger, G. M., Turk, T. M. T., et al. (2014) · Journal of Urology · doi:10.1016/j.juro.2014.05.006 · Cited by 1,099
Cochat, P., & Rumsby, G. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1301564 · Cited by 586
Lipid nanoparticle technology for therapeutic gene regulation in the liver
Witzigmann, D., Kulkarni, J. A., Leung, J., Chen, S., Cullis, P. R., & van der Meel, R. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.026 · Cited by 376
Manipulating the gut microbiota to maintain health and treat disease
Scott, K. P., Antoine, J.-M., Midtvedt, T., & van Hemert, S. (2015) · Microbial Ecology in Health & Disease · doi:10.3402/mehd.v26.25877 · Cited by 281
Phenotype-Genotype Correlations and Estimated Carrier Frequencies of Primary Hyperoxaluria
Hopp, K., Cogal, A. G., Bergstralh, E. J., Seide, B. M., Olson, J. B., Meek, A. M., Lieske, J. C., Milliner, D. S., & Harris, P. C. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014070698 · Cited by 267
Dutta, C., Avitahl-Curtis, N., Pursell, N., Larsson Cohen, M., Holmes, B., Diwanji, R., Zhou, W., Apponi, L., Koser, M., Ying, B., et al. (2016) · Molecular Therapy · doi:10.1038/mt.2016.4 · Cited by 81
Therapeutic RNA-silencing oligonucleotides in metabolic diseases
Goga, A., & Stoffel, M. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00407-5 · Cited by 58
Hepatocyte targeting via the asialoglycoprotein receptor
Ramírez-Cortés, F., & Ménová, P. (2025) · RSC Medicinal Chemistry · doi:10.1039/d4md00652f · Cited by 55
Metadata
- Authors
- Hoppe, B.
- Venue
- Nature Reviews Nephrology
- Published
- 2012-06-12
- Volume
- 8
- Issue
- 8
- Pages
- 467-475
- ISSN
- 1745-8323 (ISSN-L)
- 1759-5061
- 1759-507X
- OpenAlex
- W2072848717
- Cited by
- 312
- References
- 42
- FWCI
- 3.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.